Therapy side-effects and predictive factors for preterm delivery in patients undergoing tocolysis with atosiban or ritodrine for threatened preterm labour

References

• Bastek JA, Sammel MD, Paré E, Srinivas SK, Posencheg MA, Elovitz MA. 2008. Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. American Journal of Obstetrics and Gynecology 199:367.e1–367.e8.
   PubMed Web of Science ®Google Scholar
• Cole RM, Lamont RF. 1998. Current perspectives on drug treatment for preterm labour. Journal of Obstetrics and Gynaecology 18:309–314.
   Google Scholar
• Creasy RK. 1993. Preterm birth prevention: where are we?American Journal of Obstetrics and Gynecology 168:1223–1230.
   PubMed Web of Science ®Google Scholar
• Duley L, Bennett P. 2011. Tocolysis for women in preterm labour. Technical report. London: Royal College of Obstetricians and Gynaecologists.
   Google Scholar
• European Atosiban Study Group. 2001. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study. Acta Obstetricia et Gynecologica Scandinavica 80:413–422.
   PubMed Web of Science ®Google Scholar
• French/Australian Atosiban Investigators Group. 2001. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. European Journal of Obstetrics, Gynecology, and Reproductive Biology 98:177–185.
   PubMed Web of Science ®Google Scholar
• Fruscalzo A, Londero A, Fröhlich C, Möllmann U, Schmitz R. 2014. Quantitative elastography for cervical stiffness assessment during pregnancy. BioMed Research International. doi: 10.1155/2014/826535.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Rouse DJ. 1998. Prevention of premature birth. New England Journal of Medicine 339:313–320.
   PubMed Web of Science ®Google Scholar
• Goodwin TM, Valenzuela GJ, Silver H, Creasy G. 1996. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Atosiban study group. Obstetrics and Gynecology 88: 331–336.
   PubMed Web of Science ®Google Scholar
• Gupta RC, Foster S, Romano PM, Thomas HM. 1989. Acute pulmonary edema associated with the use of oral ritodrine for premature labor. Chest 95:479–481.
   PubMed Web of Science ®Google Scholar
• Honest H, Bachmann LM, Coomarasamy A, Gupta JK, Kleijnen J, Khan KS. 2003. Accuracy of cervical transvaginal sonography in predicting preterm birth: a systematic review. Ultrasound in Obstetrics and Gynecology 22:305–322.
   PubMed Web of Science ®Google Scholar
• Honest H, Forbes CA, Durée KH, Norman G, Duffy SB, Tsourapas A et al. 2009. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technology Assessment 13:1–627.
   PubMed Web of Science ®Google Scholar
• Husslein P, Roura LC, Dudenhausen JW, Helmer H, Frydman R, Rizzo N et al. 2007. Atosiban versus usual care for the management of preterm labor. Journal of Perinatal Medicine 35:305–313.
   PubMed Web of Science ®Google Scholar
• Husslein P. 2002. Development and clinical experience with the new evidence-based tocolytic atosiban. Acta Obstetricia et Gynecologica Scandinavica 81:633–641.
   PubMed Web of Science ®Google Scholar
• Ingemarsson I, Lamont RF. 2003. An update on the controversies of tocolytic therapy for the prevention of preterm birth. Acta Obstetricia et Gynecologica Scandinavica 82:1–9.
   PubMed Web of Science ®Google Scholar
• Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. 2001. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. American Journal of Obstetrics and Gynecology 184:946–953.
   PubMed Web of Science ®Google Scholar
• Lin CH, Lin SY, Shyu MK, Chen SU, Lee CN. 2009. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women. Journal of the Formosan Medical Association 108:493–501.
   PubMed Web of Science ®Google Scholar
• Locci M, Nazzaro G, Merenda A, Pisaturo ML, Laviscio P, Poppiti R et al. 2006. Atosiban vs ritodrine used prophylactically with cerclage in icsi pregnancies to prevent pre-term birth in women identified as being at high risk on the basis of transvaginal ultrasound scan. Journal of Obstetrics and Gynaecology 26:396–401.
   Google Scholar
• Marlow N, Wolke D, Bracewell MA, Samara M, Group EPICS. 2005. Neurologic and developmental disability at six years of age after extremely preterm birth. New England Journal of Medicine 352:9–19.
   PubMed Web of Science ®Google Scholar
• Martin JA, Kung HC, Mathews TJ, Hoyert DL, Strobino DM, Guyer B et al. 2008. Annual summary of vital statistics: 2006. Pediatrics 121: 788–801.
   PubMed Web of Science ®Google Scholar
• Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M et al. 2000. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. American Journal of Obstetrics and Gynecology 182:1191–1199.
   PubMed Web of Science ®Google Scholar
• Murray JF. 2011. Pulmonary edema: pathophysiology and diagnosis. International Journal of Tuberculosis and Lung Disease 15:155–160, i.
   PubMed Web of Science ®Google Scholar
• Papatsonis D, Flenady V, Cole S, Liley H. 2005. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews(3):CD004452.
   Google Scholar
• Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. 2009. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstetrics and Gynecology 114:631–640.
   PubMed Web of Science ®Google Scholar
• Sanu O, Lamont RF. 2010. Critical appraisal and clinical utility of atosiban in the management of preterm labor. Therapeutics and Clinical Risk Management 6:191–199.
   PubMed Web of Science ®Google Scholar
• Shim JY, Park YW, Yoon BH, Cho YK, Yang JH, Lee Y et al. 2006. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women. British Journal of Obstetrics and Gynaecology 113:1228–1234.
   Google Scholar
• Spong CY. 2007. Prediction and prevention of recurrent spontaneous preterm birth. Obstetrics and Gynecology 110:405–415.
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Carbonne B, Cabrol D. 2004. Atosiban for preterm labour. Drugs 64:375–382.
   PubMed Web of Science ®Google Scholar
• Vercauteren M, Palit S, Soetens F, Jacquemyn Y, Alahuhta S. 2009. Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiologica Scandinavica 53:701–709.
   PubMed Web of Science ®Google Scholar
• Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HC, Bloemenkamp KW et al. 2009. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (apostel-i trial). BMC Pregnancy Childbirth 9:38.
   PubMed Web of Science ®Google Scholar
• Wex J, Connolly M, Rath W. 2009. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation. BMC Pregnancy Childbirth 9:23.
   PubMed Web of Science ®Google Scholar
• Worldwide Atosiban versus Beta-agonists Study Group. 2001. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. British Journal of Obstetrics and Gynaecology 108:133–142.
   Google Scholar